Back to search
FDAFDA · Food and drugs·Recall number D-0432-2017

Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81

Published January 25, 2017 · Recall initiated: December 2, 2016

Summary

FDA records drug Class III recall D-0432-2017, published January 25, 2017 and initiated December 2, 2016. Recalling firm: Shire PLC; Status: Terminated; Reported quantity: 4,520 bottles; Lot: Lot Number AE7363A, exp 06/30/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

What to do

Voluntary: Firm initiated

Get an email if PENTASA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PENTASA
Manufacturer
Shire PLC
Distributor
Nationwide and Puerto Rico
UPC
0354092191123
Lot
Lot Number AE7363A, exp 06/30/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pentasa (mesalamine) Controlled-Release Capsules, 250 mg, 240 count bottle, Rx only, Manufactured for Shire US Inc., Lexington, MA --- NDC 54092-189-81 recalled?

Yes. FDA published recall D-0432-2017 on January 25, 2017. Reported hazard: Presence of Foreign Tablets/Capsules; 500 mg capsules were found in bottles labeled to contain 250 mg capsules

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PENTASA. UPC: 0354092191123.